Together, we create a future of hope and healing.

At Hiba Pharma, we are committed to excellence in oncology pharmaceutical manufacturing. Through cutting-edge technology, rigorous quality standards, and innovative research, we develop life-saving cancer treatments that improve patient outcomes.

With a focus on precision, compliance, and accessibility, we strive to set new benchmarks in oncology care. Our mission is clear: to advance pharmaceutical quality and enrich lives by providing safe, effective, and reliable therapies for those who need them most.

our journey

Launched UAE-based operations with a strategic focus on oncology manufacturing.

Established business office at Dubai Science Park.

Licensing & Tech transfer agreements with Kelix Bio and Novugen Pharma.

Ground breaking in KEZAD, Abu Dhabi.

Licensing & Tech Transfer agreement with SAKAR Healthcare.


Civil and structural work.

MEP and commissioning.

Facility inauguration and EDE cGMP approval.

Tech transfer Phase.

GMP inspections GCC, SFDA.

Launched UAE-based operations with a strategic focus on oncology manufacturing.

Established business office at Dubai Science Park.
Licensing & Tech transfer agreements with Kelix Bio and Novugen Pharma.

Ground breaking in KEZAD, Abu Dhabi.
Licensing & Tech Transfer agreement with SAKAR Healthcare.

Civil and structural work.

MEP and commissioning.

Facility inauguration and EDE cGMP approval. Tech transfer Phase.

GMP inspections GCC, SFDA.

Our facility

HIBA Pharma takes pride in operating state-of-the-art manufacturing facility in in Kezad, Abu Dhabi, UAE, equipped with the latest industry technologies.
Our facility is being built to comply with cGMP regulations and international standards, ensuring the highest safety, efficacy, and quality standards in every product we manufacture.
We are proud to be the only local facility producing sterile injectable oncology medications. We stand at the forefront of pharmaceutical advancements, reinforcing our commitment to addressing unmet medical needs.

Our Portfolio

HIBA Pharma is dedicated to provide high-quality pharmaceutical solutions that address critical healthcare challenges. Our diverse product portfolio spans multiple therapeutic categories that include but not limited to:

Our partners

HIBA PHARMA actively seeks partnerships with forward-thinking pharmaceutical firms that share our commitment to innovation, quality, and patient-centric approach through Licensing, Technology Transfer and Contract Manufacturing.

LATEST NEWS

LATEST NEWS

Launched UAE-based operations with a strategic focus on oncology manufacturing. Established business office at Dubai Science Park.

Licensing & Tech transfer agreements with Kelix Bio and Novugen Pharma. Ground breaking in KEZAD, Abu Dhabi.

Licensing & Tech Transfer agreement with SAKAR Healthcare. Civil and structural work.

MEP and commissioning.

Facility inauguration and EDE cGMP approval. Tech transfer Phase. GMP inspections GCC, SFDA.

Size
20,000 M²
Current Area
10,000 M²
Future Expansion Area
6,150 M²
Production Area
810 M²
Laboratory Area
2600 M²
Warehouses
Capacity
More than 0.5 Billion
Tablets per year
More than 0.25 Billion
Capsules per year
More than 40 Million
Vials per year
Packaging
More than 100 Million
Packs per year
Scroll to Top